Lipid Microemboli introduced into the cardiopulmonary circuit are reported to be a key mechanism involved in neurological injury. Moreover, they may also impact other organs.
Remowell2 has a unique and patented technology to reduce Lipid Microemboli, among other unique features.
*A.dell’Amore et al. Efficacy of a New Oxygenator-Integrated Fat and Leukocyte Removal Device. Asian Cardiovasc Thorac Ann 2010;0:1–5
DISCOVER MORE ABOUT CARDIOPULMONARY PRODUCT PORTFOLIO